Gara Jalqabaatti › Miidhaa Qaraa Hamaa
Qorannoo klinikaalii Miidhaa Qaraa Hamaa Ameerikaa Keessatti hirmaatuu
Qorannoo 13 Miidhaa Qaraa Hamaa f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Durham, NCQorannoo 5
- Mountain View, CAQorannoo 5
- New York City, NYQorannoo 5
- Washington, DCQorannoo 5
- Cleveland, OHQorannoo 5
- Nashville, TNQorannoo 5
- Seattle, WAQorannoo 5
- Rochester, MNQorannoo 4
- Oklahoma City, OKQorannoo 4
- Peoria, ILQorannoo 4
- Sarasota, FLQorannoo 4
- Ann Arbor, MIQorannoo 4
- Greenburgh, NYQorannoo 4
- Boston, MAQorannoo 4
- St. Petersburg, FLQorannoo 4
- Detroit, MIQorannoo 4
- Portland, ORQorannoo 4
- Fort Worth, TXQorannoo 4
- Edison, NJQorannoo 4
- Birmingham, ALQorannoo 4
- Sacramento, CAQorannoo 4
- Evanston, ILQorannoo 4
- Denver, COQorannoo 4
- Long Beach, CAQorannoo 4
- Orange, CAQorannoo 4
- Gainesville, FLQorannoo 4
- Toledo, OHQorannoo 4
- Charlottesville, VAQorannoo 4
- Houston, TXQorannoo 4
- Boise, IDQorannoo 4
- West Jordan, UTQorannoo 4
- Fresno, CAQorannoo 4
- The Bronx, NYQorannoo 4
- Charleston, SCQorannoo 4
- Somerville, MAQorannoo 4
Naannoon
- AlabamaQorannoo 4
- CaliforniaQorannoo 6
- ColoradoQorannoo 4
- Distaarikii KoloombiyaaQorannoo 4
- FloridaQorannoo 4
- IdahoQorannoo 4
- IllinoisQorannoo 6
- MassachusettsQorannoo 4
- MichiganQorannoo 4
- MinnesotaQorannoo 5
- New JerseyQorannoo 4
- New YorkQorannoo 5
- North CarolinaQorannoo 5
- OhioQorannoo 5
- OklahomaQorannoo 4
- OregonQorannoo 4
- PennsylvaniaQorannoo 3
- South CarolinaQorannoo 4
- TennesseeQorannoo 5
- TexasQorannoo 4
- UtahQorannoo 5
- VirginiaQorannoo 5
- WashingtonQorannoo 5
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
Observational, Non-interventional Biomarker and Endotyping Study
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07675265Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07613099Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HT31-1 for Treating ARDS
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07449572Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT06476132JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 31-Ado-2026 · NCT06701669JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 31-Ado-2026 · NCT06701682JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 31-Ado-2026 · NCT06701656JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 31-Ado-2026 · NCT06703073Anti-CD14 Treatment With IC14 in Hospitalized ARDS Patients
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ado-2026 · NCT06513949Lung Injury is One of the Primary Causes of Morbidity and Mortality in Critically Ill Patients. These Patients Will be Monitored for: 1) Immune Cell Activation 2) Blood-based Biomarkers. In Vitro Models Derived From These Samples Will be Treated With Novel Agent PIP-2 to Evaluate Its Efficacy.
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 21 hanga 90 · Saalaa hunda · Haaromfame 10-Wax-2026 · NCT07125079Recovery of Physical Function After Critical Illness In Older Adults
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 28-Cam-2026 · NCT07225257Clinical Decision Support Tool in PARDS Pilot Study
Namoota walitti qabaa jira
1 Month – 18 Years · Saalaa hunda · Haaromfame 14-Elb-2026 · NCT04068012This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction
Namoota walitti qabaa jiraSadarkaa 2Hojjettoota fayyaa simatamoo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Ama-2026 · NCT06853223Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.